Citation Impact
Citing Papers
Viral RNA Patterns and High Viral Load Reliably Define Oropharynx Carcinomas with Active HPV16 Involvement
2012
Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial
2011
Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United States
2011 Standout
E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx— ECOG-ACRIN Cancer Research Group
2017
Subtypes of HPV-Positive Head and Neck Cancers Are Associated with HPV Characteristics, Copy Number Alterations, PIK3CA Mutation, and Pathway Signatures
2016
Reverse-Phase Protein Array Profiling of Oropharyngeal Cancer and Significance of PIK3CA Mutations in HPV-Associated Head and Neck Cancer
2014
Evidence for a Role of the PD-1:PD-L1 Pathway in Immune Resistance of HPV-Associated Head and Neck Squamous Cell Carcinoma
2013
Induction Chemotherapy and Cetuximab for Locally Advanced Squamous Cell Carcinoma of the Head and Neck: Results From a Phase II Prospective Trial
2009
Randomized Trial of Postoperative Reirradiation Combined With Chemotherapy After Salvage Surgery Compared With Salvage Surgery Alone in Head and Neck Carcinoma
2008
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis
2008 Standout
Prognostic Significance of p16 INK4A and Human Papillomavirus in Patients With Oropharyngeal Cancer Treated on TROG 02.02 Phase III Trial
2010
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Comprehensive genomic characterization of head and neck squamous cell carcinomas
2015 StandoutNature
Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions
2018
Oral diseases: a global public health challenge
2019 Standout
Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer
2013
Head and neck squamous cell carcinoma
2020 Standout
A Phase I Study of CUDC-101, a Multitarget Inhibitor of HDACs, EGFR, and HER2, in Combination with Chemoradiation in Patients with Head and Neck Squamous Cell Carcinoma
2015
Head and neck cancers—major changes in the American Joint Committee on cancer eighth edition cancer staging manual
2017 Standout
Human Papillomavirus Testing in Head and Neck Carcinomas: Guideline From the College of American Pathologists
2017
EGFR Antagonists in Cancer Treatment
2008 Standout
Association of p16INK4a overexpression with improved outcomes in young patients with squamous cell cancers of the oral tongue
2010
Current clinical outcomes demand new treatment options for SCCHN
2005
Incidence and survival trends of head and neck squamous cell carcinoma in the Netherlands between 1989 and 2011
2014
Concurrent Chemoradiotherapy vs Radiotherapy Alone in Stage II Nasopharyngeal Carcinoma: Phase III Randomized Trial
2011
Targeting hypoxia in cancer therapy
2011 Standout
Hemorrhagic complications in a phase II study of sunitinib in patients of nasopharyngeal carcinoma who has previously received high-dose radiation
2011
Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients With Postradiation Persistently Detectable Plasma Epstein-Barr Virus Deoxyribonucleic Acid
2014
Repopulation of cancer cells during therapy: an important cause of treatment failure
2005
Hypoxia, inflammation, and the tumor microenvironment in metastatic disease
2010
Oxidative stress, inflammation, and cancer: How are they linked?
2010 Standout
Oral cavity tumors in younger patients show a poor prognosis and do not contain viral RNA
2013
Human papillomavirus detection and comorbidity: critical issues in selection of patients with oropharyngeal cancer for treatment De-escalation trials
2013
Panitumumab plus radiotherapy versus chemoradiotherapy in patients with unresected, locally advanced squamous-cell carcinoma of the head and neck (CONCERT-2): a randomised, controlled, open-label phase 2 trial
2015
HPV Detection Methods in Head and Neck Cancer
2012
Synchronous cancers in patients with head and neck cancer
2013
Pancreatic cancer
2020 Standout
Incidence trends in head and neck cancers and human papillomavirus (HPV)-associated oropharyngeal cancer in Canada, 1992–2009
2012
Upfront surgery versus definitive chemoradiotherapy in patients with human Papillomavirus-associated oropharyngeal squamous cell cancer
2018
Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
2016
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer: an Italian validation study
2011
A comparison of clinically utilized human papillomavirus detection methods in head and neck cancer
2011
Intensity-modulated radiotherapy prolongs the survival of patients with nasopharyngeal carcinoma compared with conventional two-dimensional radiotherapy: A 10-year experience with a large cohort and long follow-up
2015
Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: Which anatomic structures are affected and can they be spared by IMRT?
2004
Reduced-dose radiotherapy for human papillomavirus-associated squamous-cell carcinoma of the oropharynx: a single-arm, phase 2 study
2017
Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter study
2011
Quality Assessment in Supportive Care in Head and Neck Cancer
2019
Do high-risk human papillomaviruses cause oral cavity squamous cell carcinoma?
2014
Drug penetration in solid tumours
2006 Standout
Heterogeneity of the Head and Neck Squamous Cell Carcinoma Immune Landscape and Its Impact on Immunotherapy
2019
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Head and neck cancer
2008 Standout
Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy
2014
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
OPTIMA: a phase II dose and volume de-escalation trial for human papillomavirus-positive oropharyngeal cancer
2018
Validation of the ICON-S staging for HPV-associated oropharyngeal carcinoma using a pre-defined treatment policy
2017
AI in health and medicine
2022 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
High Frequency of Activating <emph type="ital">PIK3CA</emph> Mutations in Human Papillomavirus–Positive Oropharyngeal Cancer<alt-title><emph type="ital">PIK3CA</emph> in HPV+ Oropharyngeal Squamous Cell Carcinoma</alt-title>
2013
The association between T-stage and clinical nodal metastasis In HPV-positive oropharyngeal cancer
2013
Pancreatic cancer
2016 Standout
Vertically transmitted nasopharyngeal infection of the human papillomavirus: Does it play an aetiological role in nasopharyngeal cancer?
2014
Nasopharyngeal carcinoma
2019 Standout
Long-term outcomes of intensity-modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: An analysis of survival and treatment toxicities
2013
Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer
2010 Standout
Late toxicities after conventional radiation therapy alone for nasopharyngeal carcinoma
2012
The molecular biology of head and neck cancer
2010 Standout
Patterns of failure in high-metastatic node number human papillomavirus-positive oropharyngeal carcinoma
2018
EGF–ERBB signalling: towards the systems level
2006 Standout
How Does Magnetic Resonance Imaging Influence Staging According to AJCC Staging System for Nasopharyngeal Carcinoma Compared With Computed Tomography?
2008
Long-Term Quality of Life After Swallowing and Salivary-Sparing Chemo–Intensity Modulated Radiation Therapy in Survivors of Human Papillomavirus–Related Oropharyngeal Cancer
2015
Pancreatic Adenocarcinoma
2014 Standout
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Cellular senescence in ageing: from mechanisms to therapeutic opportunities
2020 Standout
MATH, a novel measure of intratumor genetic heterogeneity, is high in poor-outcome classes of head and neck squamous cell carcinoma
2012
Recognition of nonkeratinizing morphology in oropharyngeal squamous cell carcinoma – a prospective cohort and interobserver variability study*
2011
Global cancer statistics
2011 Standout
Validation of Methods for Oropharyngeal Cancer HPV Status Determination in US Cooperative Group Trials
2012
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice
2015
HPV-associated head and neck cancer: a virus-related cancer epidemic
2010 Standout
A phase II study of primary reirradiation in squamous cell carcinoma of head and neck
2006
Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinoma
2012
Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
2016
Increasing prevalence rates of HPV attributable oropharyngeal squamous cell carcinomas in the Netherlands as assessed by a validated test algorithm
2012
Systematic review and meta-analyses of intensity-modulated radiation therapy versus conventional two-dimensional and/or or three-dimensional radiotherapy in curative-intent management of head and neck squamous cell carcinoma
2018
Prognostic Impact of AJCC/UICC 8th Edition New Staging Rules in Oropharyngeal Squamous Cell Carcinoma
2017
Low etiologic fraction for high-risk human papillomavirus in oral cavity squamous cell carcinomas
2012
Molecular Aspects of Head and Neck Cancer Therapy
2015
Treatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors
2012
Nasopharyngeal carcinoma
2015 Standout
Cancer stem cell enrichment marker CD98: A prognostic factor for survival in patients with human papillomavirus-positive oropharyngeal cancer
2013
Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer
1996
Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer
2020
Remodelling the extracellular matrix in development and disease
2014 Standout
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
2010 Standout
The head and neck cancer immune landscape and its immunotherapeutic implications
2016
The use of ultrasound in the search for the primary site of unknown primary head and neck squamous cell cancers
2014
Genomic insights into head and neck cancer
2016
Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition
2013
Genomic alterations in head and neck squamous cell carcinoma determined by cancer gene-targeted sequencing
2015
Lysyl oxidase enzymatic function increases stiffness to drive colorectal cancer progression through FAK
2012
The course of health-related quality of life in head and neck cancer patients treated with chemoradiation: A prospective cohort study
2014
Targeting Epidermal Growth Factor Receptor in Head and Neck Cancer
2022
Mechanism-driven biomarkers to guide immune checkpoint blockade in cancer therapy
2016 Standout
Epidemiology and Clinical Aspects of HPV in Head and Neck Cancers
2012
The battle against nasopharyngeal cancer
2012
AHNS Series-Do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors
2015
Nonendemic HPV-Positive Nasopharyngeal Carcinoma: Association With Poor Prognosis
2014
Critical Review: Transoral Laser Microsurgery and Robotic-Assisted Surgery for Oropharynx Cancer Including Human Papillomavirus–Related Cancer
2012
Oropharyngeal Cancer Epidemic and Human Papillomavirus
2010
p16 expression as a surrogate marker for HPV‐related oropharyngeal carcinoma: A guide for interpretative relevance and consistency
2011
Evolution of treatment for nasopharyngeal cancer – Success and setback in the intensity-modulated radiotherapy era
2014
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Patient-Derived Xenografts for Prognostication and Personalized Treatment for Head and Neck Squamous Cell Carcinoma
2018
Prevalence of Oral HPV Infection in the United States, 2009-2010
2012 Standout
Human Papillomavirus and Diseases of the Upper Airway: Head and Neck Cancer and Respiratory Papillomatosis
2012
Pancreatic Cancer
2010 Standout
Locally advanced head and neck squamous cell cancer: treatment choice based on risk factors and optimizing drug prescription
2012
From HPV-positive towards HPV-driven oropharyngeal squamous cell carcinomas
2015
The molecular landscape of head and neck cancer
2018 Standout
New treatment strategies for HPV-positive head and neck cancer
2013
Transoral robotic surgery and human papillomavirus status: Oncologic results
2010
TAME: development of a new method for summarising adverse events of cancer treatment by the Radiation Therapy Oncology Group
2007
A Phase III Study of Late Course Accelerated Hyperfractionated Radiotherapy Versus Conventionally Fractionated Radiotherapy in Patients With Nasopharyngeal Carcinoma
2011
Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer
2012
The meaning of p16ink4aexpression in tumors
2011
The clinical impact of HPV tumor status upon head and neck squamous cell carcinomas
2013
Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
2012
Different prognostic models for different patient populations: validation of a new prognostic model for patients with oropharyngeal cancer in Western Europe
2015
Accuracy of Computed Tomography for Predicting Pathologic Nodal Extracapsular Extension in Patients With Head-and-Neck Cancer Undergoing Initial Surgical Resection
2013
Prognostic factors and long‐term survivorship in patients with recurrent or metastatic carcinoma of the head and neck
2004
The DAHANCA 6 randomized trial: Effect of 6 vs 5 weekly fractions of radiotherapy in patients with glottic squamous cell carcinoma
2015
Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck – A systematic review and meta-analysis
2011
Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial
2013
Preclinical evaluation of sunitinib as single agent or in combination with chemotherapy in nasopharyngeal carcinoma
2010
Artificial intelligence in radiation oncology
2020
Angiogenesis as a therapeutic target
2005 StandoutNature
Regulatory networks defining EMT during cancer initiation and progression
2013 Standout
Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer
2007 Standout
Prevalence of human papillomavirus in oropharyngeal and nonoropharyngeal head and neck cancer—systematic review and meta‐analysis of trends by time and region
2012
Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial
2011
Human papillomavirus-related oropharyngeal cancer
2017
Phase I/II Study of Docetaxel, Cisplatin, and Concomitant Boost Radiation for Locally Advanced Squamous Cell Cancer of the Head and Neck
2006
Prognostic Value of the Cumulative Cisplatin Dose During Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A Secondary Analysis of a Prospective Phase III Clinical Trial
2016
Eurogin Roadmap: Comparative epidemiology of HPV infection and associated cancers of the head and neck and cervix
2013
An International Collaboration to Harmonize the Quantitative Plasma Epstein-Barr Virus DNA Assay for Future Biomarker-Guided Trials in Nasopharyngeal Carcinoma
2013
Tirapazamine, Cisplatin, and Radiation Versus Cisplatin and Radiation for Advanced Squamous Cell Carcinoma of the Head and Neck (TROG 02.02, HeadSTART): A Phase III Trial of the Trans-Tasman Radiation Oncology Group
2010
The “New” Head and Neck Cancer Patient—Young, Nonsmoker, Nondrinker, and HPV Positive: Evaluation
2014
Head and Neck Cancer
2020 Standout
Prevention and Treatment of Dysphagia and Aspiration After Chemoradiation for Head and Neck Cancer
2006
Long‐term prognosis and risk factors among patients with HPV‐associated oropharyngeal squamous cell carcinoma
2013
The extracellular matrix: A dynamic niche in cancer progression
2012 Standout
Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status
2014
Genetic Landscape of Human Papillomavirus–Associated Head and Neck Cancer and Comparison to Tobacco-Related Tumors
2015
Initial Symptoms in Patients With HPV-Positive and HPV-Negative Oropharyngeal Cancer
2014
Worldwide Trends in Incidence Rates for Oral Cavity and Oropharyngeal Cancers
2013 Standout
Impact of treatment expertise on the outcome of patients with head and neck cancer treated within 6 randomized trials
2018
Increasing Incidence of Oral Tongue Squamous Cell Carcinoma in Young White Women, Age 18 to 44 Years
2011
Deintensification Candidate Subgroups in Human Papillomavirus–Related Oropharyngeal Cancer According to Minimal Risk of Distant Metastasis
2013
Molecular Pathology of Head and Neck Cancer: Implications for Diagnosis, Prognosis, and Treatment
2008
No evidence for active human papillomavirus (HPV ) in fields surrounding HPV ‐positive oropharyngeal tumors
2013
Long-Term Results of RTOG 91-11: A Comparison of Three Nonsurgical Treatment Strategies to Preserve the Larynx in Patients With Locally Advanced Larynx Cancer
2012 Standout
Meta-Analyses of Chemotherapy for Locally Advanced and Metastatic Pancreatic Cancer
2007
Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma
2013
Increasing prevalence of human papillomavirus–positive oropharyngeal cancers among older adults
2018
Treatment deintensification in human papillomavirus‐positive oropharynx cancer: Outcomes from the National Cancer Data Base
2017
Tobacco Smoking and Increased Risk of Death and Progression for Patients With p16-Positive and p16-Negative Oropharyngeal Cancer
2012
The Expanding Role of Systemic Therapy in Head and Neck Cancer
2004
Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16‐driven oropharyngeal squamous cell carcinoma
2017
ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck
2011
Chemotherapy Options for Patients With Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck
2006
Management of Nasopharyngeal Carcinoma: Current Practice and Future Perspective
2015
New Paradigms and Future Challenges in Radiation Oncology: An Update of Biological Targets and Technology
2013
Differences in the Prevalence of Human Papillomavirus (HPV) in Head and Neck Squamous Cell Cancers by Sex, Race, Anatomic Tumor Site, and HPV Detection Method
2016
Evaluating the impact of patient, tumor, and treatment characteristics on the development of jaw complications in patients treated for oral cancers: A SEER-Medicare analysis
2012
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis
2015
Prognostic Significance of [18F]-Misonidazole Positron Emission Tomography–Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02
2006
Poor prognosis in human papillomavirus–positive oropharyngeal squamous cell carcinomas that overexpress hypoxia inducible factor‐1α
2016
p16 status, pathologic and clinical characteristics, biomolecular signature, and long‐term outcomes in head and neck squamous cell carcinomas of unknown primary
2013
Refining American Joint Committee on Cancer/Union for International Cancer Control TNM Stage and Prognostic Groups for Human Papillomavirus–Related Oropharyngeal Carcinomas
2015
Preterm labor: One syndrome, many causes
2014 StandoutScience
Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma
2014
Extracapsular spread and adjuvant therapy in human papillomavirus‐related, p16‐positive oropharyngeal carcinoma
2011
Oropharyngeal carcinoma related to human papillomavirus
2010
Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer
2011 Standout
HPV, hypoxia and radiation response in head and neck cancer
2018
Global cancer statistics, 2012
2015 Standout
Validation of the 8th edition UICC/AJCC TNM staging system for HPV associated oropharyngeal cancer patients managed with contemporary chemo-radiotherapy
2019
Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
2014 Standout
Use of Larynx-Preservation Strategies in the Treatment of Laryngeal Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update
2017
Quality of Life Supersedes the Classic Prognosticators for Long-Term Survival in Locally Advanced Non–Small-Cell Lung Cancer: An Analysis of RTOG 9801
2009
Randomized Phase III Trial to Test Accelerated Versus Standard Fractionation in Combination With Concurrent Cisplatin for Head and Neck Carcinomas in the Radiation Therapy Oncology Group 0129 Trial: Long-Term Report of Efficacy and Toxicity
2014
The expanding role of cytopathology in the diagnosis of HPV‐related squamous cell carcinoma of the head and neck
2013
Cisplatin Every 3 Weeks Versus Weekly With Definitive Concurrent Radiotherapy for Squamous Cell Carcinoma of the Head and Neck
2018
Incidence and pattern of second primary malignancies in patients with index oropharyngeal cancers versus index nonoropharyngeal head and neck cancers
2013
Lysyl Oxidase: From Basic Science to Future Cancer Treatment
2012
Treatment at high‐volume facilities and academic centers is independently associated with improved survival in patients with locally advanced head and neck cancer
2017
Molecular characterization of p16-immunopositive but HPV DNA-negative oropharyngeal carcinomas
2013
Works of Jonathan Harris being referenced
Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024
2009
Human Papillomavirus and Overall Survival After Progression of Oropharyngeal Squamous Cell Carcinoma
2014
Final report of RTOG 9610, a multi‐institutional trial of reirradiation and chemotherapy for unresectable recurrent squamous cell carcinoma of the head and neck
2007
Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-14)
2008
Evaluation of tumor angiogenesis measured with microvessel density (MVD) as a prognostic indicator in nasopharyngeal carcinoma: Results of RTOG 9505
2005
Phase II Study of External Irradiation and Weekly Paclitaxel for Nonmetastatic, Unresectable Pancreatic Cancer: RTOG-98-12
2004
Final Results of Local-Regional Control and Late Toxicity of RTOG 9003: A Randomized Trial of Altered Fractionation Radiation for Locally Advanced Head and Neck Cancer
2014
Multi-Institutional Trial of Accelerated Hypofractionated Intensity-Modulated Radiation Therapy for Early-Stage Oropharyngeal Cancer (RTOG 00-22)
2009
RTOG 96-10: reirradiation with concurrent hydroxyurea and 5-fluorouracil in patients with squamous cell cancer of the head and neck
2001
Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer
2010 Standout
Emotional well‐being does not predict survival in head and neck cancer patients
2007
p16 Protein Expression and Human Papillomavirus Status As Prognostic Biomarkers of Nonoropharyngeal Head and Neck Squamous Cell Carcinoma
2014
Preliminary Results of Radiation Therapy Oncology Group 97-03: A Randomized Phase II Trial of Concurrent Radiation and Chemotherapy for Advanced Squamous Cell Carcinomas of the Head and Neck
2004
Survival outcomes by tumor human papillomavirus (HPV) status in stage III-IV oropharyngeal cancer (OPC) in RTOG 0129
2009
Disadvantage of Men Living Alone Participating in Radiation Therapy Oncology Group Head and Neck Trials
2006
An Eastern Cooperative Oncology Group Phase II Study of Single Agent DHAD, VP-16, Aclacinomycin, or Spirogermanium in Metastatic Pancreatic Cancer
1994
Postoperative Chemoradiotherapy and Cetuximab for High-Risk Squamous Cell Carcinoma of the Head and Neck: Radiation Therapy Oncology Group RTOG-0234
2014
Phase II Randomized Trial of Postoperative Chemoradiation Plus Cetuximab for High-risk Squamous Cell Carcinoma of the Head and Neck (RTOG 0234)
2009
Concomitant boost radiation and concurrent cisplatin for advanced head and neck carcinomas: preliminary results of a phase II trial of the RTOG (99-14)
2002
Phase II Multi-institutional Study of Intensity Modulated Radiation Therapy (IMRT) +/− Chemotherapy for Nasopharyngeal (NPC) Carcinoma: Preliminary Clinical Results of RTOG 0225
2008
p16 expression as a human papillomavirus (HPV)-independent prognostic biomarker in non-oropharyngeal squamous cell carcinoma (non-OPSCC).
2013
Intensity-Modulated Radiation Therapy With or Without Chemotherapy for Nasopharyngeal Carcinoma: Radiation Therapy Oncology Group Phase II Trial 0225
2009
Validation of Lysyl Oxidase As a Prognostic Marker for Metastasis and Survival in Head and Neck Squamous Cell Carcinoma: Radiation Therapy Oncology Group Trial 90-03
2009
Institutional Clinical Trial Accrual Volume and Survival of Patients With Head and Neck Cancer
2014
Phase II Study of Low-Dose Paclitaxel and Cisplatin in Combination With Split-Course Concomitant Twice-Daily Reirradiation in Recurrent Squamous Cell Carcinoma of the Head and Neck: Results of Radiation Therapy Oncology Group Protocol 9911
2007
Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14
2005
Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522
2014